Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Heart
Frontiers | Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF - ScienceDirect
Estimating the Lifetime Benefits of Treatments for Heart Failure - ScienceDirect
Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study - eClinicalMedicine
Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan | NEJM
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
JCM | Free Full-Text | Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
Forest plot of indirect comparisons used to estimate the effects of... | Download Scientific Diagram
Kidney Research and Clinical Practice
Frontiers | Sacubitril/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats
Insights into implementation of sacubitril/valsartan into clinical practice - Martens - 2018 - ESC Heart Failure - Wiley Online Library
Emerging Treatment Approaches to Improve Outcomes in Patients with Heart Failure | Cardiology Discovery
PDF) Estimating the Lifetime Benefits of Treatments for Heart Failure
Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study - eClinicalMedicine
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
Frontiers | Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study
Frontiers | Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - ScienceDirect
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Heart
Practical guidance on the use of sacubitril/valsartan for heart failure | SpringerLink
